Highlights Granules India Limited

Stocks

532482

INE101D01020

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 12:13:05 09/06/2026 pm IST			5-day change	1st Jan Change
773.50 ^INR	+0.85%		-0.33%	+29.35%

01/05	Choice Equity Broking Downgrades Granules India to Add from Buy; Price Target is INR835	MT
29/04	Granules India Limited, Q4 2026 Earnings Call, Apr 29, 2026

Highlights

29/04	Granules India Q4 consol profit 2.02 billion rupees	RE
29/04	Granules India Limited Recommends Final Dividend for the Financial Year 2025-2026	CI
29/04	Granules India's fourth-quarter profit jumps on strong demand	RE
29/04	Granules India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05/03	Granules India Arm Gets "No Action Indicated" Status from US FDA for Viginia Unit; Shares Up 3%	MT
24/02	Granules India: Analysts Bet on Continued Upside
23/01	Granules India quarterly profit jumps on strong demand in North America, Europe	RE
23/01	Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
08/01	Granules India Arm Gets US FDA's Tentative Nod for Amphetamine Extended-Release Tablets	MT
22/12	Granules India Arm Gets US FDA's Tentative Nod for Generic Amphetamine Extended-Release Tablets	MT
22/12	Granules says unit gets US FDA tentative approval for generic amphetamine extended-release orally disintegrating tablets	RE
19/12	Granules says FDA inspection at unit concludes with five observations	RE
04/12	Granules India's US Arm Gets Zero Observations from US FDA After GMP Inspection	MT
01/12	Granules India Limited Inaugurates Two Advanced Centres of Excellence At the Technology Research Park of IIT Hyderabad	CI
27/11	Granules India Forms Step-Down Subsidiary in Canada	MT
13/11	Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
13/11	Granules approved acquisition of 100% stake in Optus 1039 GmbH	RE
13/11	Granules India Limited Announces Executive Changes	CI
13/11	Granules India posts higher quarterly profit on strong North America, Europe sales	RE
13/11	Granules India Q2 consol profit 1.31 bln rupees	RE
11/11	Granules India Arm Gets US FDA Nod for Product from Hyderabad, India Unit	MT
29/25/29	Granules India Gets US FDA's Voluntary Action Indicated Classification for Bonthapally, India Unit	MT
13/25/13	Granules India Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
12/25/12	Paracetamol maker Granules India's quarterly profit drops on supply backlog	RE
12/25/12	Granules India Q1 consol profit 1.13 billion rupees	RE